Bioventus Inc. reports results for the quarter ended June 30 - Earnings Summary

Bioventus

05/08/2026 14:31

Bioventus Inc. BVS.OQ reported quarterly adjusted earnings of 54 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 21 cents.  The mean expectation of five analysts for the quarter was for earnings of 22 cents per share. Wall Street expected results to range from 20 cents to 23 cents per share.
Revenue rose 3.8% to $153.21 million from a year ago; analysts expected $155.64 million. 
Bioventus Inc.'s reported EPS for the quarter was 47 cents​.
The company reported quarterly net income of $33.44 million.
Bioventus Inc. shares had risen by 42.2% this quarter and gained 80.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.8% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Bioventus Inc. is $15.00, about 10.5% above its last closing price of $13.42
This summary was machine generated from LSEG data August 5 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.22
0.54
Beat
Mar. 31 2026 
0.10
0.15
Beat
Dec. 31 2025 
0.22
0.24
Beat
Sep. 30 2025 
0.12
0.15
Beat